🇺🇸 FDA
Pipeline program

Placebo (Metoprolol succinate), Metoprololsuccinat STADA® 47,5 mg Retardtabletten, Aficamten, DOBUTAMINE , Placebo (Aficamten)

CY 6032

Phase 3 small_molecule active

Quick answer

Placebo (Metoprolol succinate), Metoprololsuccinat STADA® 47,5 mg Retardtabletten, Aficamten, DOBUTAMINE , Placebo (Aficamten) for Symptomatic Obstructive Hypertrophic Cardiomyopathy is a Phase 3 program (small_molecule) at Cytokinetics (Ireland) Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Cytokinetics (Ireland) Limited
Indication
Symptomatic Obstructive Hypertrophic Cardiomyopathy
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials